Kanawha Capital Management LLC Reduces Position in The Clorox Company $CLX

Kanawha Capital Management LLC lessened its stake in shares of The Clorox Company (NYSE:CLXFree Report) by 5.0% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 3,800 shares of the company’s stock after selling 200 shares during the quarter. Kanawha Capital Management LLC’s holdings in Clorox were worth $456,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in CLX. Hsbc Holdings PLC boosted its stake in shares of Clorox by 118.8% during the first quarter. Hsbc Holdings PLC now owns 1,085,661 shares of the company’s stock valued at $159,699,000 after purchasing an additional 589,544 shares during the period. Robeco Institutional Asset Management B.V. lifted its stake in Clorox by 101.8% in the second quarter. Robeco Institutional Asset Management B.V. now owns 1,083,723 shares of the company’s stock worth $130,123,000 after acquiring an additional 546,761 shares during the period. KBC Group NV boosted its holdings in Clorox by 688.7% in the first quarter. KBC Group NV now owns 587,679 shares of the company’s stock valued at $86,535,000 after acquiring an additional 513,171 shares in the last quarter. AQR Capital Management LLC boosted its holdings in Clorox by 412.1% in the first quarter. AQR Capital Management LLC now owns 598,758 shares of the company’s stock valued at $88,167,000 after acquiring an additional 481,846 shares in the last quarter. Finally, Goldman Sachs Group Inc. raised its holdings in Clorox by 147.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 707,005 shares of the company’s stock worth $104,107,000 after purchasing an additional 421,453 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Insider Buying and Selling at Clorox

In other news, COO Eric H. Reynolds sold 15,041 shares of the firm’s stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the transaction, the chief operating officer directly owned 54,221 shares in the company, valued at $6,711,475.38. This trade represents a 21.72% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.63% of the stock is owned by insiders.

Clorox Stock Performance

Shares of Clorox stock opened at $119.73 on Friday. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The firm has a market capitalization of $14.58 billion, a P/E ratio of 18.36, a P/E/G ratio of 0.99 and a beta of 0.52. The business has a fifty day simple moving average of $121.61 and a two-hundred day simple moving average of $127.73. The Clorox Company has a 12 month low of $116.53 and a 12 month high of $171.37.

Clorox (NYSE:CLXGet Free Report) last announced its quarterly earnings data on Thursday, July 31st. The company reported $2.87 EPS for the quarter, beating the consensus estimate of $2.24 by $0.63. The business had revenue of $1.99 billion during the quarter, compared to analyst estimates of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The company’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same quarter last year, the firm posted $1.82 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, equities analysts forecast that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd will be issued a dividend of $1.24 per share. The ex-dividend date is Wednesday, October 22nd. This represents a $4.96 annualized dividend and a dividend yield of 4.1%. Clorox’s dividend payout ratio (DPR) is presently 76.07%.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on CLX. BNP Paribas Exane cut their target price on shares of Clorox from $118.00 to $110.00 and set an “underperform” rating on the stock in a research note on Friday. Wells Fargo & Company reduced their price target on shares of Clorox from $130.00 to $125.00 and set an “equal weight” rating on the stock in a research report on Thursday, September 25th. UBS Group reduced their price target on shares of Clorox from $134.00 to $128.00 and set a “neutral” rating on the stock in a research report on Wednesday, October 8th. Morgan Stanley reduced their price target on shares of Clorox from $150.00 to $137.00 and set an “equal weight” rating on the stock in a research report on Friday, August 1st. Finally, Deutsche Bank Aktiengesellschaft reduced their price target on shares of Clorox from $135.00 to $128.00 and set a “hold” rating on the stock in a research report on Monday, October 13th. One investment analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and four have assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Reduce” and a consensus price target of $130.20.

Check Out Our Latest Report on Clorox

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.